Literature DB >> 33643897

MicroRNAs and Long Non-Coding RNAs as Regulators of NANOG Expression in the Development of Oral Squamous Cell Carcinoma.

Gašper Grubelnik1, Emanuela Boštjančič1, Aleksandar Aničin2,3, Tadej Dovšak3,4, Nina Zidar1.   

Abstract

NANOG is a stem cell transcription factor that is believed to play an important role in the development of oral squamous cell carcinoma (OSCC), but there is limited data regarding the role of long non-coding RNAs (lncRNAs) and microRNAs (miRNAs) in the regulation of NANOG expression. We therefore analyzed expression of NANOG, NANOG-regulating miRNAs and lncRNAs in OSCC cancerogenesis, using oral biopsy samples from 66 patients including normal mucosa, dysplasia, and OSCC. Expression analysis of NANOG, miR-34a, miR-145, RoR, SNHG1, AB209630, and TP53 was performed using qPCR and immunohistochemistry for NANOG protein detection. NANOG protein showed no staining in normal mucosa, very weak in low-grade dysplasia, and strong staining in high-grade dysplasia and OSCC. NANOG, miR-145, RoR, and SNHG1 showed up-regulation, TP53 and miR-34a showed down-regulation, and AB209630 showed variable expression during cancerogenesis. NANOG mRNA was up-regulated early in cancerogenesis, before strong protein expression can be detected. NANOG was in correlation with miR-145 and RoR. Our results suggest that miRNAs and lncRNAs, particularly miR-145 and RoR, might be important post-transcription regulatory mechanisms of NANOG in OSCC cancerogenesis. Furthermore, NANOG protein detection has a diagnostic potential for oral high-grade dysplasia, distinguishing it from low-grade dysplasia and non-neoplastic reactive lesions.
Copyright © 2021 Grubelnik, Boštjančič, Aničin, Dovšak and Zidar.

Entities:  

Keywords:  NANOG; cancerogenesis; long non-coding RNAs; microRNAs; oral squamous cell carcinoma

Year:  2021        PMID: 33643897      PMCID: PMC7906007          DOI: 10.3389/fonc.2020.579053

Source DB:  PubMed          Journal:  Front Oncol        ISSN: 2234-943X            Impact factor:   6.244


  53 in total

1.  Endogenous miRNA sponge lincRNA-RoR regulates Oct4, Nanog, and Sox2 in human embryonic stem cell self-renewal.

Authors:  Yue Wang; Zhenyu Xu; Junfeng Jiang; Chen Xu; Jiuhong Kang; Lei Xiao; Minjuan Wu; Jun Xiong; Xiaocan Guo; Houqi Liu
Journal:  Dev Cell       Date:  2013-03-28       Impact factor: 12.270

2.  miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions.

Authors:  Chih-Hung Chou; Sirjana Shrestha; Chi-Dung Yang; Nai-Wen Chang; Yu-Ling Lin; Kuang-Wen Liao; Wei-Chi Huang; Ting-Hsuan Sun; Siang-Jyun Tu; Wei-Hsiang Lee; Men-Yee Chiew; Chun-San Tai; Ting-Yen Wei; Tzi-Ren Tsai; Hsin-Tzu Huang; Chung-Yu Wang; Hsin-Yi Wu; Shu-Yi Ho; Pin-Rong Chen; Cheng-Hsun Chuang; Pei-Jung Hsieh; Yi-Shin Wu; Wen-Liang Chen; Meng-Ju Li; Yu-Chun Wu; Xin-Yi Huang; Fung Ling Ng; Waradee Buddhakosai; Pei-Chun Huang; Kuan-Chun Lan; Chia-Yen Huang; Shun-Long Weng; Yeong-Nan Cheng; Chao Liang; Wen-Lian Hsu; Hsien-Da Huang
Journal:  Nucleic Acids Res       Date:  2018-01-04       Impact factor: 16.971

3.  LncRNA AB209630 inhibits gemcitabine resistance cell proliferation by regulating PI3K/AKT signaling in pancreatic ductal adenocarcinoma.

Authors:  Libin Wang; Feng Wang; Li Na; Jingjing Yu; Liya Huang; Zhi-Qiang Meng; Zhen Chen; Hao Chen; Liu-Lu Ming; Yong-Qiang Hua
Journal:  Cancer Biomark       Date:  2018       Impact factor: 4.388

4.  Down Regulation of miR-34a and miR-143 May Indirectly Inhibit p53 in Oral Squamous Cell Carcinoma: a Pilot Study.

Authors:  Mayakannan Manikandan; Arunagiri Kuha Deva Magendhra Rao; Ganesan Arunkumar; Kottayasamy Seenivasagam Rajkumar; Ramamurthy Rajaraman; Arasambattu Kannan Munirajan
Journal:  Asian Pac J Cancer Prev       Date:  2015

5.  MicroRNA expression profiling of oral carcinoma identifies new markers of tumor progression.

Authors:  L Scapoli; A Palmieri; L Lo Muzio; F Pezzetti; C Rubini; A Girardi; F Farinella; M Mazzotta; F Carinci
Journal:  Int J Immunopathol Pharmacol       Date:  2010 Oct-Dec       Impact factor: 3.219

Review 6.  An evolutionary perspective on field cancerization.

Authors:  Kit Curtius; Nicholas A Wright; Trevor A Graham
Journal:  Nat Rev Cancer       Date:  2017-12-08       Impact factor: 60.716

7.  Low miR-143/miR-145 Cluster Levels Induce Activin A Overexpression in Oral Squamous Cell Carcinomas, Which Contributes to Poor Prognosis.

Authors:  Andreia Bufalino; Nilva K Cervigne; Carine Ervolino de Oliveira; Felipe Paiva Fonseca; Priscila Campioni Rodrigues; Carolina Carneiro Soares Macedo; Lays Martin Sobral; Marcia Costa Miguel; Marcio Ajudarte Lopes; Adriana Franco Paes Leme; Daniel W Lambert; Tuula A Salo; Luiz Paulo Kowalski; Edgard Graner; Ricardo D Coletta
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

Review 8.  Cancer Stem Cells in Oral Cavity Squamous Cell Carcinoma: A Review.

Authors:  Ranui Baillie; Swee T Tan; Tinte Itinteang
Journal:  Front Oncol       Date:  2017-06-02       Impact factor: 6.244

Review 9.  Prognostic significance of NANOG expression in solid tumors: a meta-analysis.

Authors:  Lingqiong Zhao; Jie Liu; Shu Chen; Chun Fang; Xianquan Zhang; Zhibin Luo
Journal:  Onco Targets Ther       Date:  2018-09-06       Impact factor: 4.147

Review 10.  Long non-coding RNAs in Oral squamous cell carcinoma: biologic function, mechanisms and clinical implications.

Authors:  Lei Zhang; Xiang Meng; Xin-Wei Zhu; Deng-Cheng Yang; Ran Chen; Yong Jiang; Tao Xu
Journal:  Mol Cancer       Date:  2019-05-27       Impact factor: 27.401

View more
  1 in total

Review 1.  Development of head and neck pathology in Europe.

Authors:  Henrik Hellquist; Abbas Agaimy; Göran Stenman; Alessandro Franchi; Alfons Nadal; Alena Skalova; Ilmo Leivo; Nina Zidar; Roderick H W Simpson; Pieter J Slootweg; Juan C Hernandez-Prera; Alfio Ferlito
Journal:  Virchows Arch       Date:  2022-01-14       Impact factor: 4.064

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.